Exagen Inc.XGNNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank74
5Y CAGR+1.6%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

5Y CAGR
+1.6%/yr
Long-term compound
Percentile
P74
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 20258.55%
Q3 2025-0.84%
Q2 20253.02%
Q1 20259.80%
Q4 20240.40%
Q3 2024-2.88%
Q2 2024-0.74%
Q1 2024-13.70%
Q4 20237.39%
Q3 2023-4.84%
Q2 20230.58%
Q1 2023-7.24%
Q4 2022-9.46%
Q3 20229.67%
Q2 20226.18%
Q1 20222.97%
Q4 20212.38%
Q3 20213.20%
Q2 202111.26%
Q1 20211.12%
Q4 20207.90%
Q3 202011.19%
Q2 2020-14.02%
Q1 202021.62%
Q4 20198.34%
Q3 20190.05%
Q2 201918.17%
Q1 201917.56%
Q4 20186.57%
Q3 20183.05%
Q2 20181.81%
Q1 20180.00%
Q4 20150.46%
Q3 2015-4.92%
Q2 20156.99%
Q1 2015-0.42%
Q4 20144.32%
Q3 20149.80%
Q2 201422.98%
Q1 201433.16%